IBB icon

iShares Biotechnology ETF

431 hedge funds and large institutions have $6B invested in iShares Biotechnology ETF in 2015 Q4 according to their latest regulatory filings, with 78 funds opening new positions, 130 increasing their positions, 152 reducing their positions, and 57 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

14% less repeat investments, than reductions

Existing positions increased: 130 | Existing positions reduced: 152

42% less call options, than puts

Call options by funds: $795M | Put options by funds: $1.37B

Holders
431
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
32
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$795M
Puts
$1.37B
Net Calls
Net Calls Change

Top Buyers

1 +$398M
2 +$82.1M
3 +$64.2M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$19.4M
5
Parallax Volatility Advisers
Parallax Volatility Advisers
California
+$16.9M

Top Sellers

1 -$369M
2 -$260M
3 -$232M
4
Goldman Sachs
Goldman Sachs
New York
-$162M
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$131M
Name Holding Trade Value Shares
Change
Change in
Stake
201
$1.03M
202
$1.02M
203
$1M
204
$992K
205
$990K
206
$988K
207
$988K
208
$987K
209
$985K
210
$967K
211
$958K
212
$958K
213
$933K
214
$931K
215
$930K
216
$918K
217
$915K
218
$905K
219
$880K
220
$875K
221
$874K
222
$851K
223
$848K
224
$846K
225
$846K